Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
AA5QDALLERGAN FNDG 15/25 | 8,68% | 0 | 99,84% | 3,80% | 2025-03-15 | 130,22 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8,14% | 50 K | 74,10% | 4,75% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7,72% | 24 K | 76,91% | 4,63% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7,69% | 15 K | 77,85% | 4,85% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6,31% | 750 K | 89,19% | 4,55% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
5,74% | 26 K | 90,47% | 3,20% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,71% | 25 K | 85,02% | 4,25% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,65% | 0 | 88,43% | 4,45% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,56% | 0 | 91,78% | 4,70% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,52% | 889 K | 89,99% | 4,40% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,50% | 40 K | 92,87% | 4,75% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,49% | 723 K | 93,62% | 4,88% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,47% | 8 M | 92,40% | 4,63% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,44% | 8,02 M | 100,75% | 5,50% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,42% | 744 K | 88,76% | 4,05% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,41% | 4,04 M | 99,95% | 3,80% | 2025-03-15 | 2,89 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,40% | 43 K | 94,81% | 4,85% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,37% | 6,2 M | 100,34% | 5,40% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,25% | 16,26 M | 104,05% | 5,60% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,24% | 0 | 99,68% | 3,60% | 2025-05-14 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,23% | 215 K | 101,19% | 5,35% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,16% | 0 | 93,88% | 4,30% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
5,06% | 0 | 96,24% | 4,50% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,99% | 1,34 M | 97,08% | 4,55% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,85% | 11,19 M | 101,26% | 5,05% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,85% | 8,65 M | 102,37% | 5,20% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,68% | 11,27 M | 94,26% | 3,20% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,59% | 7,94 M | 101,18% | 4,88% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,59% | 2,97 M | 101,72% | 4,95% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,44% | 0 | 98,59% | 3,20% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,41% | 896 K | 99,50% | 4,25% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,40% | 2,9 M | 100,68% | 4,65% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,39% | 3,5 M | 101,40% | 4,80% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,38% | 2,2 M | 97,72% | 2,95% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
4,31% | 2,1 M | 100,91% | 4,80% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
XXS162262122ALLERGAN FNDG 17/29 | 3,88% | 0 | 93,62% | 2,13% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
3,87% | 0 | 95,98% | 2,63% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
3,86% | 0 | 96,53% | 2,95% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
3,07% | 0 | 89,86% | 1,25% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
3,01% | 0 | 102,15% | 3,80% | 2025-03-15 | 1,27 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,90% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,88% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,85% | 0 | 99,26% | 2,63% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,83% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
2,83% | 0 | 97,34% | 2,13% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,75% | 0 | 97,88% | 2,13% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,65% | 0 | 95,19% | 0,75% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
2,35% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 3,80% | 2025-03-15 | — | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
— | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |